Hadir Farouk

Dr. Hadir Farouk

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2015 in African Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
HFHadir Farouk
Hadir Farouk
SSS Mahmoud Sawsan
S Mahmoud Sawsan
ABA El Sayeh Bahia
A El Sayeh Bahia
AOA Sharaf Ola
A Sharaf Ola
Grapefruit (Citrus Paradise, family Rutaceae) is a citrus fruit that is low in calories and rich in dietary fibers. Sibutramine (Sibutramine hydrochloride monohydrate) is an anti-obesity drug that enhances satiety. The effect of grapefruit juice and sibutramine on body weight and neurotransmitters controlling appetite was investigated in obese rats. Rats were assigned to two dietary groups for 3 weeks; control group (n=6) was fed commercial standard pellets diet and obese group (n=24) was fed cafeteria diet (hypercaloric diet consisting of highly palatable food). The effect of sibutramine and grapefruit juice was studied on obese rats. Statistical difference and interactions were evaluated through one-way analysis of variance test (one-way ANOVA) followed by Dunnett’s test was used for means of different groups. For all statistical tests done, a 0.05 level of probability was used as the criterion for significance. Grapefruit juice produced its weight reduction effect after 1 week of administration and lasted till the end of the experiment and did not affect brain neurotransmitters. Sibutramine produced its weight reduction effect after 1 week of administration and lasted for only 2 weeks and produced an increase in brain noradrenaline while grapefruit juice produced its effect from the first week till the end of the study. It can be concluded that grapefruit juice is better than sibutramine since its effect lasted till the end of the experiment and also did not affect brain noradrenaline. Key words: Obesity, sibutramine, grapefruit juice, cafeteria diet.

25 March 2026 in The Egyptian Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
HFHadir Farouk
Hadir Farouk
Central obesity, dysglycemia, hypertension, and dyslipidaemia are key cardiometabolic risk factors that collectively increase the risk of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM). These factors are collectively referred to as Metabolic Syndrome (MetS). Its prevalence has reached pandemic levels worldwide, mirroring trends in sedentary lifestyles and obesity, and has become a major public health concern. This review provides a comprehensive overview of current knowledge on MetS, including its complex multifactorial pathogenesis, evolving diagnostic criteria, and broad clinical consequences. The central roles of insulin resistance and dysfunctional visceral adipose tissue are explored, with emphasis on the interplay among oxidative stress, chronic inflammation, and hormonal dysregulation. Evidence-based management strategies are reviewed, ranging from lifestyle modification to advanced pharmacologic therapies and metabolic surgery. Emerging concepts—including the roles of gut microbiota, circadian rhythm disruption, and novel therapeutic targets—are also discussed. Early diagnosis, individualized risk stratification, and a multisystem management approach are emphasized as essential to reducing the growing burden of MetS-related morbidity and mortality.

8 September 2026 in Toxicology Mechanisms and Methods
Verified
Journal Article
Closed access
HFHadir Farouk
Hadir Farouk
SESalma A. El-Marasy
Salma A. El-Marasy
MKMarwa S. Khattab
Marwa S. Khattab
YEYasmin M. Abd El-Aziz
Yasmin M. Abd El-Aziz
RMRasha E. Mostafa
Rasha E. Mostafa
1. IntroductionThe neuropsychiatric condition known as hepatic encephalopathy (HE) occurs due to chronic or acute liver disease (Rose et al., 2020). HE symptoms include neuropsychiatric disorders a...

7 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
RARania Ahmed
Rania Ahmed
HFHadir Farouk
Hadir Farouk
YHYosra A. Hussien
Yosra A. Hussien
MSMarwa EL Araby Shabana
Marwa EL Araby Shabana
MNMaha Nasr
Maha Nasr
Background/Objectives: The clinical efficacy of cyclophosphamide, a commonly used chemotherapeutic drug, is often restricted by off-target neurotoxicity, which is primarily caused by oxidative stress, neuroinflammation, and apoptosis. With the aim of finding natural neuroprotective agents, pterostilbene was investigated in this study, either in conventional form or when solubilized as a nanoemulsion, for its neuroprotective potential against cyclophosphamide-induced neurotoxicity. Methods: Female Wistar rats were orally administered pterostilbene, either in its conventional form (50 mg/kg p.o) or nanoemulsion form (25 and 50 mg/kg p.o), for 15 days. Cyclophosphamide was injected once on day 14 (200 mg/kg ip). Results: Our findings revealed that administering pterostilbene as a nanoemulsion or in its conventional powder form managed to counteract the cyclophosphamide-induced intoxication features via disrupting the oxidative stress–inflammasome–cytokine axis; by upregulating cortical and hippocampal PPAR-γ, Nrf2, HO-1, BCL2 levels and the BCL2/Bax ratio; and downregulating NLRP3, IL-1β, COX-2, Bax and GFAP levels. Further histopathological and immunohistochemical evaluation confirmed the improved neuronal morphology, reduced degeneration and apoptosis, restoration of cortical and hippocampal architecture, and normalization of GFAP expression levels, approaching those of the control group upon treatment with either conventional or nanoformulated pterostilbene. Conclusions: The promising nature of the nanoemulsion formulation, particularly when administered at the high dose level, was evidenced, hence emphasizing the important role of proper formulation of natural bioactives such as pterostilbene in maximizing their therapeutic potential.

1 November 2020 in Egyptian Journal of Chemistry
Verified
Journal Article
Closed access
HFHadir Farouk
Hadir Farouk
MSMuhammed A. Saad
Muhammed A. Saad
SMSawsan S. Mahmoud
Sawsan S. Mahmoud
MEMohammed F. El-Yamany
Mohammed F. El-Yamany
OSOla A. Sharaf
Ola A. Sharaf
EEEzz E. El-Denshary
Ezz E. El-Denshary
Metabolic syndrome is a cluster of cardiovascular and metabolic risk factors that include impaired glucose metabolism and obesity. The use of nutraceuticals is an ideal choice for controlling this disorder. The aim of the present study is to investigate the effect (-) hydroxycitric acid present in garcinia fruit rind and (+) hydroxycitric acid present in hibiscus calyx on metabolic syndrome and compare it to that of metformin. Metabolic syndrome was induced in rats by ingestion of high fat high fructose (HFHF) diet for 90 days. Metformin (500 mg/Kg animal b.wt.), garcinia (1000 mg/Kg animal b.wt.) and hibiscus (250 mg/Kg animal b.wt) were orally administered throughout the last 30 days of the HFHF diet regimen. Both garcinia and hibiscus were effective in reducing serum blood glucose and insulin levels. The effect of garcinia on blood glucose was comparable to that of metformin, while the effect of hibiscus on insulin and HOMA-IR was comparable to that of metformin. Both were able to reduce serum leptin level. All treated groups showed a significant decrease in total cholesterol level. Only hibiscus was able to normalize liver function while garcinia failed to reduce the elevated liver function. As a conclusion we would recommend the use of hibiscus over garcinia to overcome the adverse effects of metabolic syndrome.